Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

I

IBIO

iBio, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$1.31

+0.77%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

IBIO: FY25 Deep Dive

iBio Inc FY25 at $0M. NI $-18M; EPS $-1.75.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.